This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Filmus, J Articles by Buick, R N Search for Related Content PubMed PubMed Citation Articles by Filmus, J Articles by Buick, R N

 Previous Article  |  Next Article 

Mol Cell Biol. 1987 January; 7(1): 251-257

Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants.

ABSTRACT

We have recently reported (J. Filmus, M. N. Pollak, R. Cailleau, and R. N. Buick, Biochem. Biophys. Res. Commun. 128:898-905, 1985) that MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited in vitro pharmacological doses of EGF. We have derived several MDA-468 clonal variants which are resistant to EGF-induced growth inhibition. These clones had a number of EGF receptors, similar to normal human fibroblasts, and had lost the EGF receptor gene amplification. Karyotype analysis showed that MDA-468 cells had an abnormally banded region (ABR) in chromosome 7p which was not present in the variants. It was shown by in situ hybridization that the amplified EGF receptor sequences were located in that chromosome, 7pABR. Five of the six variants studied were able to generate tumors in nude mice, but their growth rate was significantly lower than that of tumors derived from the parental cell line. The variant that was unable to produce tumors was found to be uniquely dependent on EGF for growth in soft agar.

This article has been cited by other articles:

• Cai, Z., Chen, Z., Bailey, K. E., Scollard, D. A., Reilly, R. M., Vallis, K. A. (2008). Relationship Between Induction of Phosphorylated H2AX and Survival in Breast Cancer Cells Exposed to 111In-DTPA-hEGF. JNM 49: 1353-1361 [Abstract] [Full Text]  
• Chung, C. H., Ely, K., McGavran, L., Varella-Garcia, M., Parker, J., Parker, N., Jarrett, C., Carter, J., Murphy, B. A., Netterville, J., Burkey, B. B., Sinard, R., Cmelak, A., Levy, S., Yarbrough, W. G., Slebos, R. J.C., Hirsch, F. R. (2006). Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas. JCO 24: 4170-4176 [Abstract] [Full Text]  
• Scartozzi, M., Bearzi, I., Berardi, R., Mandolesi, A., Fabris, G., Cascinu, S. (2004). Epidermal Growth Factor Receptor (EGFR) Status in Primary Colorectal Tumors Does Not Correlate With EGFR Expression in Related Metastatic Sites: Implications for Treatment With EGFR-Targeted Monoclonal Antibodies. JCO 22: 4772-4778 [Abstract] [Full Text]  
• Luwor, R. B., Johns, T. G., Murone, C., Huang, H-J. S., Cavenee, W. K., Ritter, G., Old, L. J., Burgess, A. W., Scott, A. M. (2001). Monoclonal Antibody 806 Inhibits the Growth of Tumor Xenografts Expressing Either the de2-7 or Amplified Epidermal Growth Factor Receptor (EGFR) but not Wild-Type EGFR. Cancer Res. 61: 5355-5361 [Abstract] [Full Text]  
• Busse, D., Doughty, R. S., Ramsey, T. T., Russell, W. E., Price, J. O., Flanagan, W. M., Shawver, L. K., Arteaga, C. L. (2000). Reversible G1 Arrest Induced by Inhibition of the Epidermal Growth Factor Receptor Tyrosine Kinase Requires Up-regulation of p27KIP1 Independent of MAPK Activity. J. Biol. Chem. 275: 6987-6995 [Abstract] [Full Text]  
• Velu, T., Beguinot, L, Vass, W., Willingham, M., Merlino, G., Pastan, I, Lowy, D. (1987). Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. Science 238: 1408-1410 [Abstract]  
• Csordas, G., Santra, M., Reed, C. C., Eichstetter, I., McQuillan, D. J., Gross, D., Nugent, M. A., Hajnoczky, G., Iozzo, R. V. (2000). Sustained Down-regulation of the Epidermal Growth Factor Receptor by Decorin. A MECHANISM FOR CONTROLLING TUMOR GROWTH IN VIVO. J. Biol. Chem. 275: 32879-32887 [Abstract] [Full Text]  
• Santra, M., Eichstetter, I., Iozzo, R. V. (2000). An Anti-oncogenic Role for Decorin. DOWN-REGULATION OF ErbB2 LEADS TO GROWTH SUPPRESSION AND CYTODIFFERENTIATION OF MAMMARY CARCINOMA CELLS. J. Biol. Chem. 275: 35153-35161 [Abstract] [Full Text]